Roles of MT-ND1 in Cancer

Abstract

The energy shift toward glycolysis is one of the hallmarks of cancer. Complex I is a vital enzyme complex necessary for oxidative phosphorylation. The mitochondrially encoded NADH: ubiquinone oxidoreductase core subunit 1 (MT-ND1) is the largest subunit coded by mitochondria of complex I. The present study summarizes the structure and biological function of MT-ND1. From databases and literature, the expressions and mutations of MT-ND1 in a variety of cancers have been reviewed. MT-ND1 may be a biomarker for cancer diagnosis and prognosis. It is also a potential target for cancer therapy.

Keywords

mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 / cancer / biomarker / mutation

References

[1] NaithaniS, SaraccoSA, ButlerCA, et al.. Interactions among COX1, COX2, and COX3 mRNA-specific translational activator proteins on the inner surface of the mitochondrial inner membrane of Saccharomyces cerevisiae. Mol Biol Cell, 2003, 14(1): 324-333

[2] LenkaN, VijayasarathyC, MullickJ, et al.. Structural organization and transcription regulation of nuclear genes encoding the mammalian cytochrome c oxidase complex. Prog Nucleic Acid Res Mol Biol, 1998, 61: 309344

[3] GazizovaN, RakhmatullinaD, MinibayevaF. Effect of respiratory inhibitors on mitochondrial complexes and ADP/ATP translocators in the Triticum aestivum roots. Plant Physiol Biochem, 2020, 151: 601-607

[4] GiuliviC, ZhangYF, Omanska-KlusekA, et al.. Mitochondrial dysfunction in autism. JAMA, 2010, 304(21): 2389-2396

[5] HolzknechtM, Guerrero-NavarroL, PetitM, et al.. The mitochondrial enzyme FAHD1 regulates complex II activity in breast cancer cells and is indispensable for basal BT-20 cells in vitro. FEBS Lett, 2022, 596(21): 2781-2794

[6] BaraccaA, SolainiG, SgarbiG, et al.. Severe impairment of complex I-driven adenosine triphosphate synthesis in leber hereditary optic neuropathy cybrids. Arch Neurol, 2005, 62(5): 730-736

[7] HuoponenK. Leber hereditary optic neuropathy: clinical and molecular genetic findings. Neurogenetics, 2001, 3(3): 119-125

[8] LinJ, ZhaoCB, LuJH, et al.. Novel mutations m.3959G>A and m.3995A>G in mitochondrial gene MT-ND1 associated with MELAS. Mitochondrial DNA, 2014, 25(1): 56-62

[9] LenazG, BaraccaA, CarelliV, et al.. Bioenergetics of mitochondrial diseases associated with mtDNA mutations. Biochim Biophys Acta, 2004, 1658(1–2): 89-94

[10] MitchellAL, ElsonJL, HowellN, et al.. Sequence variation in mitochondrial complex I genes: mutation or polymorphism?. J Med Genet, 2006, 43(2): 175-179

[11] SimonDK, FriedmanJ, BreakefieldXO, et al.. A heteroplasmic mitochondrial complex I gene mutation in adult-onset dystonia. Neurogenetics, 2003, 4(4): 199-205

[12] JinX, ZhangJ, YiQ, et al.. Leber’s Hereditary Optic Neuropathy Arising From the Synergy Between ND1 3635G>A Mutation and Mitochondrial YARS2 Mutations. Invest Ophthalmol Vis Sci, 2021, 62(7): 22

[13] LinY, XuX, ZhaoD, et al.. A novel m.11406 T > A mutation in mitochondrial ND4 gene causes MELAS syndrome. Mitochondrion, 2020, 54: 57-64

[14] CieslikM, CzapskiGA, WójtowiczS, et al.. Alterations of Transcription of Genes Coding Anti-oxidative and Mitochondria-Related Proteins in Amyloid beta Toxicity: Relevance to Alzheimer’s Disease. Mol Neurobiol, 2020, 57(3): 1374-1388

[15] AndersonWM, FisherRR. The subunit structure of bovine heart mitochondrial transhydrogenase. Biochim Biophys Acta, 1981, 635(1): 194-199

[16] WallaceDC. Mitochondrial DNA sequence variation in human evolution and disease. Proc Natl Acad Sci U S A, 1994, 91(19): 8739-8746

[17] MontoyaJ, Lopez-PerezMJ. Mitochondrial heterogeneity in Aspergillus nidulans: in vivo protein biosynthetic activities of the mitochondrial populations. Rev Esp Fisiol, 1980, 36(4): 427-431

[18] OjalaD, MontoyaJ, AttardiG. tRNA punctuation model of RNA processing in human mitochondria. Nature, 1981, 290(5806): 470-474

[19] BrayF, FerlayJ, SoerjomataramI, et al.. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249

[20] HuangX, ZhuX, YuY, et al.. Dissecting miRNA signature in colorectal cancer progression and metastasis. Cancer Lett, 2021, 501: 66-82

[21] AkouchekianM, HoushmandM, AkbariMH, et al.. Analysis of mitochondrial ND1 gene in human colorectal cancer. J Res Med Sci, 2011, 16(1): 50-55

[22] KassemAM, El-GuendyN, TantawyM, et al.. Mutational hotspots in the mitochondrial D-loop region of cancerous and precancerous colorectal lesions in Egyptian patients. DNA Cell Biol, 2011, 30(11): 899-906

[23] YusnitaY, NorsiahMD, RahmanAJ. Mutations in mitochondrial NADH dehydrogenase subunit 1 (mtND1) gene in colorectal carcinoma. Malays J Pathol, 2010, 32(2): 103-110

[24] KoshikawaN, AkimotoM, HayashiJI, et al.. Association of predicted pathogenic mutations in mitochondrial ND genes with distant metastasis in NSCLC and colon cancer. Sci Rep, 2017, 7(1): 15535

[25] WeertsMJA, TimmermansEC, van de StolpeA, et al.. Tumor-Specific Mitochondrial DNA Variants Are Rarely Detected in Cell-Free DNA. Neoplasia, 2018, 20(7): 687-696

[26] XuY, ZhouJ, YuanQ, et al.. Quantitative detection of circulating MT-ND1 as a potential biomarker for colorectal cancer. Bosn J Basic Med Sci, 2021, 21(5): 577-586

[27] PinheiroM, VeigaI, PintoC, et al.. Mitochondrial genome alterations in rectal and sigmoid carcinomas. Cancer Lett, 2009, 280(1): 38-43

[28] HabanoW, NakamuraS, SugaiT. Microsatellite instability in the mitochondrial DNA of colorectal carcinomas: evidence for mismatch repair systems in mitochondrial genome. Oncogene, 1998, 17(15): 1931-1937

[29] WallaceL, MehrabiS, BacanamwoM, et al.. Expression of mitochondrial genes MT-ND1, MT-ND6, MT-CYB, MT-COI, MT-ATP6, and 12S/MT-RNR1 in colorectal adenopolyps. Tumour Biol, 2016, 37(9): 12465-12475

[30] PerouCM, SorlieT, EisenMB, et al.. Molecular portraits of human breast tumours. Nature, 2000, 406(6797): 747-52

[31] JahaniMM, Azimi MeibodyA, KarimiT, et al.. An A10398G mitochondrial DNA alteration is related to increased risk of breast cancer, and associates with Her2 positive receptor. Mitochondrial DNA A DNA Mapp Seq Anal, 2020, 31(1): 11-16

[32] ThapaS, LalrohluiF, GhatakS, et al.. Mitochondrial complex I and V gene polymorphisms associated with breast cancer in mizo-mongloid population. Breast Cancer, 2016, 23(4): 607-616

[33] ParrellaP, XiaoY, FlissM, et al.. Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res, 2001, 61(20): 7623-7626

[34] Grzybowska-SzatkowskaL, SlaskaB. Mitochondrial NADH dehydrogenase polymorphisms are associated with breast cancer in Poland. J Appl Genet, 2014, 55(2): 173-181

[35] SrigleyJR, DelahuntB, EbleJN, et al.. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol, 2013, 37(10): 1469-1489

[36] KimH, KomiyamaT, InomotoC, et al.. Mutations in the Mitochondrial ND1 Gene Are Associated with Postoperative Prognosis of Localized Renal Cell Carcinoma. Int J Mol Sci, 2016, 17(12): 2049

[37] KimH, KomiyamaT, NittaM, et al.. D-loop Mutations in Renal Cell Carcinoma Improve Predictive Accuracy for Cancer-Related Death by Integrating with Mutations in the NADH Dehydrogenase Subunit 1 Gene. Genes (Basel), 2019, 10(12): 998

[38] MayrJA, MeierhoferD, ZimmermannF, et al.. Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma. Clin Cancer Res, 2008, 14(8): 2270-2275

[39] SchutteK, BornscheinJ, MalfertheinerP. Hepatocellular carcinoma—epidemiological trends and risk factors. Dig Dis, 2009, 27(2): 80-92

[40] LiW, QiY, CuiX, et al.. Heteroplasmy and Copy Number Variations of Mitochondria in 88 Hepatocellular Carcinoma Individuals. J Cancer, 2017, 8(19): 4011-4017

[41] YinPH, WuCC, LinJC, et al.. Somatic mutations of mitochondrial genome in hepatocellular carcinoma. Mitochondrion, 2010, 10(2): 174-182

[42] LiuL, TanD, WongLJ. Somatic mutation detection in complete mitochondrial DNA of lung cancer patients. Zhongguo Fei Ai Za Zhi (Chinese), 2004, 7(2): 125-129

[43] WangL, WangJ, JiaE, et al.. Plasma RNA sequencing of extracellular RNAs reveals potential biomarkers for non-small cell lung cancer. Clin Biochem, 2020, 83: 65-73

[44] MaximoV, Sobrinho-SimoesM. Hurthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance. Virchows Arch, 2000, 437(2): 107-115

[45] MaximV, SoaresP, LimaJ, et al.. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hurthle cell tumors. Am J Pathol, 2002, 160(5): 1857-1865

[46] XuB, ReznikE, TuttleRM, et al.. Outcome and molecular characteristics of non-invasive encapsulated follicular variant of papillary thyroid carcinoma with oncocytic features. Endocrine, 2019, 64(1): 97-108

[47] PorcelliAM, GhelliA, CeccarelliC, et al.. The genetic and metabolic signature of oncocytic transformation implicates HIF1alpha destabilization. Hum Mol Genet, 2010, 19(6): 1019-1032

[48] BonoraE, PorcelliAM, GasparreG, et al.. Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III. Cancer Res, 2006, 66(12): 6087-6096

[49] JiangZ, BahrT, ZhouC, et al.. Diagnostic value of circulating cell-free mtDNA in patients with suspected thyroid cancer: ND4/ND1 ratio as a new potential plasma marker. Mitochondrion, 2020, 55: 145-153

[50] MaximoV, SoaresP, SerucaR, et al.. Microsatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinoma. Genes Chromosomes Cancer, 2001, 32(2): 136-143

[51] GhidiniM, LampisA, MirchevMB, et al.. Immune-Based Therapies and the Role of Microsatellite Instability in Pancreatic Cancer. Genes (Basel), 2020, 12(1): 33

[52] JonesJB, SongJJ, HempenPM, et al.. Detection of mitochondrial DNA mutations in pancreatic cancer offers a “mass”-ive advantage over detection of nuclear DNA mutations. Cancer Res, 2001, 61(4): 1299-1304

[53] OkadaT, MizukamiY, OnoY, et al.. Digital PCR-based plasma cell-free DNA mutation analysis for early-stage pancreatic tumor diagnosis and surveillance. J Gastroenterol, 2020, 55(12): 1183-1193

[54] WarowickaA, Wolun-CholewaM, KwasniewskaA, et al.. Alternations in mitochondrial genome in carcinogenesis of HPV positive cervix. Exp Mol Pathol, 2020, 117: 104530

[55] JarviahoT, Hurme-NiiranenA, SoiniHK, et al.. Novel non-neutral mitochondrial DNA mutations found in childhood acute lymphoblastic leukemia. Clin Genet, 2018, 93(2): 275-285

[56] LinnartzB, AnglmayerR, ZanssenS. Comprehensive scanning of somatic mitochondrial DNA alterations in acute leukemia developing from myelodysplastic syndromes. Cancer Res, 2004, 64(6): 1966-1971

[57] IommariniL, KurelacI, CapristoM, et al.. Different mtDNA mutations modify tumor progression in dependence of the degree of respiratory complex I impairment. Hum Mol Genet, 2014, 23(6): 1453-1466

[58] GuneyAI, ErgecDS, TavukcuHH, et al.. Detection of mitochondrial DNA mutations in nonmuscle invasive bladder cancer. Genet Test Mol Biomarkers, 2012, 16(7): 672-678

[59] DmitrenkoV, ShostakK, BoykoO, et al.. Reduction of the transcription level of the mitochondrial genome in human glioblastoma. Cancer Lett, 2005, 218(1): 99-107

[60] JerónimoC, NomotoS, CaballeroOL, et al.. Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene, 2001, 20(37): 5195-5198

[61] GuerraF, KurelacI, CormioA, et al.. Placing mitochondrial DNA mutations within the progression model of type I endometrial carcinoma. Hum Mol Genet, 2011, 20(12): 2394-2405

[62] TsujiA, AkaoT, MasuyaT, et al.. IACS-010759, a potent inhibitor of glycolysis-deficient hypoxic tumor cells, inhibits mitochondrial respiratory complex I through a unique mechanism. J Biol Chem, 2020, 295(21): 7481-7491

[63] LomeliN, DiK, PearreDC, et al.. Mitochondrial-associated impairments of temozolomide on neural stem/progenitor cells and hippocampal neurons. Mitochondrion, 2020, 52: 56-66

[64] LiuQ, SunY, FeiZ, et al.. Leptin promotes fatty acid oxidation and OXPHOS via the c-Myc/PGC-1 pathway in cancer cells. Acta Biochim Biophys Sin (Shanghai), 2019, 51(7): 707-714

[65] JiS, ZhengZ, LiuS, et al.. Resveratrol promotes oxidative stress to drive DLC1 mediated cellular senescence in cancer cells. Exp Cell Res, 2018, 370(2): 292-302

[66] SitarekP, SynowiecE, KowalczykT, et al.. An In Vitro Estimation of the Cytotoxicity and Genotoxicity of Root Extract from Leonurus sibiricus L. Overexpressing AtPAP1 against Different Cancer Cell Lines. Molecules, 2018, 23(8): 2049

[67] SkalaE, SynowiecE, KowalczykT, et al.. Rhaponticum carthamoides Transformed Root Extract Has Potent Anticancer Activity in Human Leukemia and Lung Adenocarcinoma Cell Lines. Oxid Med Cell Longev, 2018, 2018: 8198652

[68] LiuZ, RenB, WangY, et al.. Sesamol Induces Human Hepatocellular Carcinoma Cells Apoptosis by Impairing Mitochondrial Function and Suppressing Autophagy. Sci Rep, 2017, 7: 45728

[69] TendiEA, BosettiF, DasguptaSF, et al.. Ginkgo biloba extracts EGb 761 and bilobalide increase NADH dehydrogenase mRNA level and mitochondrial respiratory control ratio in PC12 cells. Neurochem Res, 2002, 27(4): 319-323

[70] SripadaL, SinghK, LipatovaAV, et al.. hsa-miR-4485 regulates mitochondrial functions and inhibits the tumorigenicity of breast cancer cells. J Mol Med (Berl), 2017, 95(6): 641-651

[71] GreeneJ, SegaranA, LordS. Targeting OXPHOS and the electron transport chain in cancer; Molecular and therapeutic implications. Semin Cancer Biol, 2022, 86: 851-859 Pt 2)

[72] SriramkumarS, SoodR, HuntingtonTD, et al.. Platinum-induced mitochondrial OXPHOS contributes to cancer stem cell enrichment in ovarian cancer. J Transl Med, 2022, 20(1): 246

[73] JonckheereAI, SmeitinkJA, RodenburgRJ. Mitochondrial ATP synthase: architecture, function and pathology. J Inherit Metab Dis, 2012, 35(2): 211-225

[74] ShenJ, WanJ, SongR, et al.. Peripheral blood mitochondrial DNA copy number, length heteroplasmy and breast cancer risk: a replication study. Carcinogenesis, 2015, 36(11): 1307-1313

[75] ThyagarajanB, WangR, BarceloH, et al.. Mitochondrial copy number is associated with colorectal cancer risk. Cancer Epidemiol Biomarkers Prev, 2012, 21(9): 1574-1581

[76] LeeJS, KoYG, ShinKJ, et al.. Mitochondrial DNA 4977bp deletion mutation in peripheral blood reflects atrial remodeling in patients with non-valvular atrial fibrillation. Yonsei Med J, 2015, 56(1): 53-61

[77] TanBH, SkipworthRJ, StephensNA, et al.. Frequency of the mitochondrial DNA 4977bp deletion in oesophageal mucosa during the progression of Barrett’s oesophagus. Eur J Cancer, 2009, 45(5): 736-740

[78] ShaikNA, LoneWG, KhanIA, et al.. Detection of somatic mutations and germline polymorphisms in mitochondrial DNA of uterine fibroids patients. Genet Test Mol Biomarkers, 2011, 15(7–8): 537-541

[79] GasparreG, KurelacI, CapristoM, et al.. A mutation threshold distinguishes the antitumorigenic effects of the mitochondrial gene MTND1, an oncojanus function. Cancer Res, 2011, 71(19): 6220-6229

[80] DuanK, LiuZJ, HuSQ, et al.. Lactic acid induces lactate transport and glycolysis/OXPHOS interconversion in glioblastoma. Biochem Biophys Res Commun, 2018, 503(2): 888-894

[81] GasparreG, IommariniL, PorcelliAM, et al.. An inherited mitochondrial DNA disruptive mutation shifts to homoplasmy in oncocytic tumor cells. Hum Mutat, 2009, 30(3): 391-396

[82] SchöllerE, MarksJ, MarchandV, et al.. Balancing of mitochondrial translation through METTL8-mediated m3C modification of mitochondrial tRNAs. Mol Cell, 2021, 81(23): 4810-4825